Retail Offer

• The Issue Price for the new Ordinary Shares is 3.7 pence per new Ordinary Share, representing a discount of 5.13 per cent to the closing mid-price of the Company's existing Ordinary Shares on 13 February 2025;
• The Retail Offer is available to both existing shareholders and new investors;
• There is a minimum subscription of £50 per investor in the Retail Offer;
• No commission will be charged by RetailBook on applications to the Retail Offer;
• The Retail Offer has a maximum allocation of £500,000;
• The Retail Offer is expected to close at 5 p.m. on 17 February 2025;
• Completion of the Retail Offer is conditional on completion of the Placing and Admission.

The Retail Offer

GENinCode (AIM: GENI.L), the genetics company focussed on the prevention of cardiovascular disease ("CVD") and the early detection of ovarian cancer is pleased to announce a conditional retail offer of new ordinary shares in the capital of the Company ("Ordinary Shares") via RetailBook (the "Retail Offer") at an issue price of 3.7 pence per new Ordinary Share (the "Issue Price"), being a discount of 5.13 per cent to the closing mid-price of the Company's existing Ordinary Shares on 13 February 2025. The Company is also conducting a placing of new Ordinary Shares to institutional investors by way of an accelerated bookbuilding process (the "Placing") and proposed subscription by entities associated with Nestor Oller and certain Directors (the "Subscription", together with the Placing and Retail Offer, the "Fundraising"), as announced by the Company earlier today. For the avoidance of doubt, the Retail Offer is not part of the Placing.

The Fundraising is conditional on approval of certain shareholder resolutions (at the general meeting of the Shareholders to be held on 3 March 2025. The Retail Offer is further conditional on the new Ordinary Shares to be issued pursuant to the Retail Offer and the Placing and Subscription being admitted to trading on AIM ("Admission"). Admission is expected to take place at 8:00 a.m. on 4 March 2025.

The Retail Offer will not be completed without the Placing also being completed.

The Company will use the gross proceeds of the Fundraising to fund the completion of its US regulatory and reimbursement program whilst driving commercialisation in the US, expanding its activities in the UK and Europe whilst positioning the Company on a pathway to breakeven/profitability over the medium term.

Reason for the Retail Offer

The Company values its retail shareholder base and believes that it is in the best interests of shareholders as well as wider stakeholders, to provide retail investors in the United Kingdom the opportunity to participate in the Retail Offer.

The Retail Offer is open to eligible investors resident and physically located in the United Kingdom following release of this announcement. The Retail Offer is expected to close at 5 p.m. on 17 February 2025 and may close earlier at the discretion of the Company or if it is oversubscribed.

Brokers wishing to offer their customers access to the Retail Offer and future RetailBook transactions, should contact partners@retailbook.com. Retail investors that wish to receive alerts for future RetailBook transactions should sign up here: https://www.retailbook.com/sign-up-new.

Eligibility for the Retail Offer

Some partners may only accept applications from existing shareholders and/or existing customers.

There is a minimum subscription of £50 per investor. The terms and conditions on which investors subscribe will be provided by the relevant financial intermediaries including relevant commission or fee charges. Note, no commission will be charged to investors by RetailBook in connection with the Retail Offer.

It is a term of the Retail Offer that the aggregate value of the shares available for subscription at the Issue Price does not exceed £500,000.

Further information on the Company can be found on its website at https://investors.genincode.com/.